Sunil Agarwal is Director of MyoKardia Inc. Currently has a direct ownership of 0 shares of MYOK, which is worth approximately $0. The most recent transaction as insider was on Nov 17, 2020, when has been sold 4,100 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

SUNIL AGARWAL Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 17 2020
SELL
Disposition due to a tender of shares in a change of control transaction
-
4,100 Reduced 100.0%
0 Common Stock

Also insider at

SANA
Sana Biotechnology, Inc. Healthcare
CALA
Calithera Biosciences, Inc. Healthcare
ARVN
ARVINAS, INC. Healthcare
ATXS
Astria Therapeutics, Inc. Healthcare
SA

Sunil Agarwal

Director
Seattle, WA

Track Institutional and Insider Activities on MYOK

Follow MyoKardia Inc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MYOK shares.

Notify only if

Insider Trading

Get notified when an Myo Kardia Inc insider buys or sells MYOK shares.

Notify only if

News

Receive news related to MyoKardia Inc

Track Activities on MYOK